Last reviewed · How we verify

Apiquel (AMINOREX)

FDA-approved withdrawn Small molecule Quality 13/100

Aminorex (Apiquel) is a marketed weight loss drug that stimulates the release of neurotransmitters to regulate appetite and metabolism. Its key strength lies in its unique mechanism of action, which differentiates it from other weight loss treatments. The primary risk is the patent expiry in 2028, which could lead to increased competition from generics.

At a glance

Generic nameAMINOREX
Drug classaminorex
ModalitySmall molecule
Therapeutic areaMetabolic
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: